Hitachi High-Technologies Life Science’s revenue for fiscal 2007 ended March 31 rose 9.3% to ¥933 billion ($8.1 billion) (see IBO 6/30/07) to account for 9.8% of company sales. Operating profit increased 39.4% to ¥123 billion ($385.3 million). Sales of liquid chromatographs and DNA sequencers increased. Hitachi High-Technologies opened a branch office in Moscow, Russia, in April. Jack S. Anderson retired from OI’s Board in March. In June, OI named Vice President and CFO J. Bruce Lancaster CEO and Acting President Donald P. Segers president and COO. Symyx Technologies’ CFO Jeryl L. Hilleman resigned, effective June 1. Pfeiffer Vacuum Technology AG promoted CFO Manfred Bender to CEO in June. In June, Andor Technology appointed Conor Walsh, finance director and company secretary, CEO. In April, laser firm Rofin-Sinar acquired Corelas Oy, a specialist in semiconductor, optics and fiber technology. Diploma Life Sciences’ sales for the first half of fiscal 2007 ended March 31 rose 4% to € 21.3 million ($41.4 million) (see IBO 5/31/07). The Anachem business showed good growth with service accounting for 25% of sales. A-1 envirosciences represented 25% of Life Science sales, with growth driven by the acquisition of CBISS (see IBO 1/31/07). In May, Sartorius AG opened a five-story laboratory building in Goettingen, Germany, for its biotechnology business, increasing R&D capacity by 60%. In May, Metrohm AG announced the election of former CEO Adrian Déteubdre as chairman. Metrohm AG, which has 1,400 employees, reported 2006 sales of more than CHF 300 million ($245 million). In June, Siemens Water Technologies announced the opening of its global water R&D center in Singapore. MDS Sciex’s fiscal second quarter sales rose 54%, or 5% organically, to $88.0 million (see IBO 6/15/07). The results include $29 million of Molecular Devices’ revenue for 41 days. Molecular Devices contributed 12% to Sciex’s reported growth. Mass spectrometry revenue increased 12%. Sciex’s goal for fiscal 2007 sales is $190 million. Biogen Idec elected Marijn E. Dekkers, PhD, president and CEO of Thermo Fisher Scientific, to its Board. Thermo Fisher Scientific opened an RNAi Discovery and Therapeutic Services lab at its RNAi research and production center in Lafayette, Colorado, in June. The new lab offers advanced RNAi screening and analysis services. Revenue for fiscal 2007 ended March 31 for Halma’s Health and Analysis business rose 9% to €120 million ($226.4 million), led by the Photonics and Water Sectors. Environmental Resource Associates, a Waters business, will collaborate with Scott Specialty Gases to provide air and emissions proficiency testing.